RxSight, Inc.

RXST ·Healthcare, Medical Devices, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $19.9M $16.7M $9.7M $11.8M $24.4M $14.0M $8.8M
Accounts Receivable $23.4M $30.1M $20.3M $11.0M $4.9M $2.9M
Inventory $31.6M $22.0M $17.4M $14.8M $8.0M $8.3M
Total Current Assets $287.5M $293.8M $168.4M $134.6M $176.3M $81.5M
Property, Plant & Equipment $13.1M $12.4M $10.8M $10.1M $11.2M $13.3M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $311.8M $318.6M $182.6M $150.2M $192.7M $100.7M
Liabilities
Accounts Payable $5.3M $4.5M $3.9M $2.6M $1.7M $1.1M
Total Current Liabilities $26.3M $25.9M $20.9M $17.2M $11.1M $11.6M
Long-Term Debt $0 $40.2M $39.8M $24.4M
Total Liabilities $36.1M $37.3M $22.2M $60.3M $54.5M $44.9M
Stockholders' Equity
Retained Earnings $-661.0M $-622.1M $-594.6M $-546.0M $-479.3M $-430.6M
Total Stockholders' Equity $275.7M $281.2M $160.4M $89.9M $138.2M $-430.6M $-419.8M